323 related articles for article (PubMed ID: 29496690)
1. Novel Germline
Lopez C; Abuel-Haija M; Pena L; Coppola D
Cancer Genomics Proteomics; 2018; 15(2):115-120. PubMed ID: 29496690
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.
Obayashi F; Hamada A; Yamasaki S; Kanda T; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):69-78. PubMed ID: 34984555
[TBL] [Abstract][Full Text] [Related]
3. Analysis of PTEN gene mutations in a Turkish patient with Cowden syndrome.
Soysal Y; Tate G; Polat C; Polat N; Aktepe F; Sivaci Y; Imirzalioglu N
Genet Test Mol Biomarkers; 2009 Aug; 13(4):547-51. PubMed ID: 19604110
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer.
Tate G; Suzuki T; Endo Y; Mitsuya T
Cancer Genet Cytogenet; 2008 Jul; 184(1):67-71. PubMed ID: 18558293
[TBL] [Abstract][Full Text] [Related]
5. Germline PTEN mutations in Cowden syndrome-like families.
Marsh DJ; Dahia PL; Caron S; Kum JB; Frayling IM; Tomlinson IP; Hughes KS; Eeles RA; Hodgson SV; Murday VA; Houlston R; Eng C
J Med Genet; 1998 Nov; 35(11):881-5. PubMed ID: 9832031
[TBL] [Abstract][Full Text] [Related]
6. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.
Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR
Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686
[TBL] [Abstract][Full Text] [Related]
7. Germline PTEN mutations in three families with Cowden syndrome.
Celebi JT; Ping XL; Zhang H; Remington T; Sulica VI; Tsou HC; Peacocke M
Exp Dermatol; 2000 Apr; 9(2):152-6. PubMed ID: 10772390
[TBL] [Abstract][Full Text] [Related]
8. A case of Cowden syndrome with a novel mutation in the PTEN gene.
Kawase Y; Matsudate Y; Kubo Y
J Med Invest; 2020; 67(1.2):200-201. PubMed ID: 32378608
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
10. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
[TBL] [Abstract][Full Text] [Related]
11. Germline PTEN Mutation Analysis for PTEN Hamartoma Tumor Syndrome.
Ngeow J; Eng C
Methods Mol Biol; 2016; 1388():63-73. PubMed ID: 27033071
[TBL] [Abstract][Full Text] [Related]
12. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.
Bennett KL; Mester J; Eng C
JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507
[TBL] [Abstract][Full Text] [Related]
13. [Our experience with analysis of the PTEN gene in patients suspected of having Cowden syndrome].
Vasovcák P; Foretová L; Puchmajerová A; Senkeríková M; Martínek J; Krepelová A
Klin Onkol; 2010; 23(2):111-4. PubMed ID: 20465090
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes.
Ni Y; Zbuk KM; Sadler T; Patocs A; Lobo G; Edelman E; Platzer P; Orloff MS; Waite KA; Eng C
Am J Hum Genet; 2008 Aug; 83(2):261-8. PubMed ID: 18678321
[TBL] [Abstract][Full Text] [Related]
15. Multiple primary malignancies and subtle mucocutaneous lesions associated with a novel PTEN gene mutation in a patient with Cowden syndrome: case report.
Vasovčák P; Senkeříková M; Hatlová J; Křepelová A
BMC Med Genet; 2011 Mar; 12():38. PubMed ID: 21406108
[TBL] [Abstract][Full Text] [Related]
16. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.
Ni Y; He X; Chen J; Moline J; Mester J; Orloff MS; Ringel MD; Eng C
Hum Mol Genet; 2012 Jan; 21(2):300-10. PubMed ID: 21979946
[TBL] [Abstract][Full Text] [Related]
17. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report.
Neychev V; Sadowski SM; Zhu J; Allgaeuer M; Kilian K; Meltzer P; Kebebew E
J Clin Endocrinol Metab; 2016 Feb; 101(2):353-8. PubMed ID: 26678657
[TBL] [Abstract][Full Text] [Related]
19. Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes.
Ngeow J; He X; Mester JL; Lei J; Romigh T; Orloff MS; Milas M; Eng C
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2320-7. PubMed ID: 23066114
[TBL] [Abstract][Full Text] [Related]
20. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
Ngeow J; Eng C
Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
